About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

MediGuide Registry | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDNCT02470312

MediGuide Registry

The goal of this registry/observational study is to collect data on the clinical utility of MediGuide™ system in cardiac resynchronization therapy (CRT) implantation and electrophysiology (EP) procedu...

Lead sponsor: Abbott Medical Devices•6 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Abbott Medical Devices

The intent of this worldwide registry/observational study is to understand the utility of the MediGuide™ technology in real world clinical practice during CRT implantation and study-specific-EP procedures. The study should provide an understanding of the effect of MediGuide™ technology on: * The amount of fluoroscopy time and the radiation exposure * Total procedure time * Peri-procedural clinical event rate Additionally, this study will address the following * Identification of procedural challenges which may aid in developing future MediGuide tools * Evaluation of newly available MediGuide tools during the study * Correlation between MediGuide operator experience and the radiation exposure amount and time

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Anybody coming for CRT or EP procedure utilizing MediGuide system and tools

Exclusion Criteria

•None

Related studies

RECRUITINGPhase 2

A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure

NCT07083011 · Heart Failure With Preserved Ejection Fraction

Contrast-Induced Acute Kidney Injury Prevention in Acute Heart Failure

NCT07550790 · Heart Failure Acute, Renal Dysfunction

RECRUITINGPhase 3

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

NCT07037459 · Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, and more

An Observational Study to Learn More About the Use of Vericiguat in Korean People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in Real-world Setting

NCT06148935 · Chronic Heart Failure With Reduced Ejection Fraction

A Study of Paramedic HF Management

NCT06874556 · Heart Failure

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 4, 2019Terms

Trial snapshot

StatusTERMINATED

Phase—

Enrollment578

Start dateAug 2015

Last updatedFeb 4, 2019

Condition

Heart Failure Cardiac Arrhythmia

Locations shown

John C Lincoln North Mountain Hospital

Phoenix, Arizona

Athens Regional Medical Center

Athens, Georgia

Gwinnett Medical Center

Lawrenceville, Georgia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 4, 2019Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions